Value in Health Publishes Themed Section on HTA
Value in Health announced the publication of a series of articles that delve into how health technology assessment (HTA) is [...]
Is California Planning to Sell Its Own Generic Drugs?
California's Democratic Governor Gavin Newsom earlier this month proposed his potential solution to reduce drug prices: have the state manufacture [...]
Report: Pharma Spent $120M on Lobbying Last Year
New federal disclosures revealed that 34 major pharmaceutical companies spent more than $120 million on lobbying last year, STAT reports. [...]
ICER Posts Draft Report on Sickle Cell Disease Therapies
The Institute for Clinical and Economic Review (ICER) on Thursday, Jan. 23, released a draft evidence report assessing treatments for [...]
Precision Xtract Launches ‘First-of-its-Kind’ Translation Service
Precision Xtract this week announced the launch of an innovative subscription-based translation service which gives clients the power to unmask [...]
JMCP Welcomes Prominent Researchers to Editorial Team
The Journal of Managed Care & Specialty Pharmacy (JMCP) is welcoming two prominent health care researchers to its editorial team [...]
The Importance of Collaboration in Value-Based Deals
A recent blog post on LillyPad, the official blog of Eli Lilly and Company, highlights the importance of ensuring collaboration [...]
Page Talks Patient-Centered Pathways, RWE, AI
Center for Cancer and Blood Disorders President and Director of Research Ray Page in a recent podcast posted on the [...]
Researchers Uncover Major Variations in Cancer Treatment Costs
In a recent study published in JAMA Oncology, researchers found the costs for cancer treatments and procedures were all over [...]
Study: Cancer Drug Costs Double at Hospitals
A new study by the Employee Benefit Research Institute Center for Research on Health Benefits Innovation suggests cancer medicines have [...]
Article: Health Industry ‘Ripe for Embracing Trust-Based Partnerships’
A recent article published on Future Medicine suggests the health industry is "ripe for embracing trust-based partnerships" between the pharmaceutical [...]
Bilimoria Talks Ratings of the Raters
The latest Relentless Health Value podcast features surgical oncologist Dr. Karl Bilimoria, who discusses the ratings of organizations that report [...]
Top Insurers Pledge $55M to Fund Generic Drug Development
A coalition of the nation's top insurance companies have pledged $55 million to fund the development of new generic drugs [...]
Report Calls for Hybrid Trial Design
A recent report, "Trial designs using real-world data: The changing landscape of the regulatory approval process," calls for hybrid trial [...]
CVS Releases Health Trends Report for 2020
CVS Health this week released its "Health Trends 2020" report which identifies six key trends in the health care industry, [...]
Pink Sheet Posts Analysis on ‘Muted’ J.P. Morgan Coference
The Pink Sheet in a recent analysis takes a look at J.P. Morgan's recent conference on health care at which [...]
Pfizer Looks to Secure Lead in ‘Arms Race’ for Data
As top pharmaceutical companies look to tap into the wealth of health care data from things like wearables and genetic [...]
SWHR’s Kocsis: Women Matter in Value Assessments
The National Pharmaceutical Council (NPC) recently sat down with the Society for Women's Health Research (SWHR) Vice President of Public [...]
American College of Physicians Backs Medicare for All
The nation's second-largest doctors group, the American College of Physicians (ACP), is officially endorsing Medicare for All and a public [...]
Trump Blasts HHS Secretary Over New Polling Data
President Donald Trump last week put HHS Secretary Alex Azar on blast last week after new polling data showed voters [...]
The Part D Doughnut Hole Closed, but is it too Early to Celebrate?
At the turn of the new year, the final drug cost reduction for Medicare Part D beneficiaries went into effect, [...]
AMCP Taps Makary as Closing Keynote Speaker
The Academy of Managed Care Pharmacy (AMCP) announced Johns Hopkins surgeon and professor of health policy Dr. Marty Makary would [...]
Webinar Spotlights Low-Value Care
A Jan. 15 webinar hosted by the Going Below the Surface Forum, in partnership with AcademyHealth and the National Pharmaceutical [...]
New Framework Introduces New Metric in Cost-Effectiveness Analysis
A recent article published in Value in Health proposes a new framework for valuing health outcomes in cost-effectiveness analyses and [...]
Report: Biosimilars Drive Down Prices of Biologics
A recent study published in JAMA Network Open suggests biologics filgrastim, pegfilgrastim, infliximab and insulin glargine all saw their prices [...]